| |
|
|
|
Infinity Pharmaceuticals Inc.  
|
|
1.67 0.05 (0.03%) |
06-25 14:15 |
|
Open: |
1.61 |
Pre close: |
1.62 |
Target:
|
2.03 
|
|
High: |
1.74 |
Low: |
1.59 |
Resistance:
|
1.74
2.03
|
|
Volume: |
158,020 |
Market Cap: |
95M |
Support:
|
1.53
1.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.61
|
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
1.60 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
1.59 |
Stochastic Oscillator |
%K(14,3):
|
65.36 |
|
MA(250): |
1.74  |
%D(3): |
59.63 |
|
Average Volume(K) |
3-Month: |
9183
|
52-Week |
High:
|
2.92 |
|
10-Days: |
8736 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
63.74 |
Change(%): |
-15.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.274 |
Return on Equity (ttm) |
-36.7 |
Shares Out. (M) |
56.93 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-16.2 |
Shares Float (M) |
37.81 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
-0.03 |
% Held by Insiders |
2.86 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
54.87 |
|
Forward EPS |
-0.590 |
Gross Profit (p.s.) |
0.041 |
Shares Short (K) |
283 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
-0.282 |
P/E |
-6.06 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.41 |
|
Profit Margin |
-64.01 |
Operating Cash Flow
(M) |
-11.13 |
P/S |
219776288.00 |
|
Operating Margin |
-66.68 |
Levered Free Cash Flow
(M) |
-6.54 |
P/CF |
-8.49 |
|
|
|
|
|
|
